658
Participants
Start Date
May 27, 2021
Primary Completion Date
July 28, 2026
Study Completion Date
July 28, 2026
Bimekizumab
Subjects will receive bimekizumab at pre-specified time-points.
Hs0005 50235, New York
Hs0005 50147, Hershey
Hs0005 50179, Winston-Salem
Hs0005 50151, Chapel Hill
Hs0005 50211, Durham
Hs0005 50084, Charleston
Hs0005 50236, Greenville
Hs0005 50193, Sandy Springs
Hs0005 50280, Watkinsville
Hs0005 50152, Orange Park
Hs0005 50184, Pembroke Pines
Hs0005 50199, Miami
Hs0005 50141, Tampa
Hs0005 50140, Birmingham
Hs0005 50142, Nashville
Hs0005 50425, Murray
Hs0005 50138, Columbus
Hs0005 50145, Columbus
Hs0005 50177, Cincinnati
Hs0005 50202, Fairborn
Hs0005 50234, Plainfield
Hs0005 50178, Clarkston
Hs0005 50105, St Louis
Hs0005 50194, Omaha
Hs0005 50204, Tulsa
Hs0005 50201, Arlington
Hs0005 50148, Pflugerville
Hs0005 50175, Phoenix
Hs0005 50237, Albuquerque
Hs0005 50208, Las Vegas
Hs0005 50161, Los Angeles
Hs0005 50196, Thousand Oaks
Hs0005 50220, San Diego
Hs0005 50162, Fountain Valley
Hs0005 50270, Seattle
Hs0005 50205, North Miami Beach
Hs0005 50198, Beverly
Hs0005 50146, Boston
Hs0005 50159, Portsmouth
Hs0005 50137, East Windsor
Hs0005 50200, Verona
Hs0005 50008, Johnston
Hs0005 50180, Providence
Hs0005 30015, Campbelltown
Hs0005 30016, Carlton
Hs0005 30011, East Melbourne
Hs0005 30017, Kogarah
Hs0005 30018, Parkville
Hs0005 30014, St Leonards
Hs0005 30009, Westmead
Hs0005 30012, Woolloongabba
Hs0005 40002, Leuven
Hs0005 40121, Woluwe-Saint-Lambert
Hs0005 40313, Pleven
Hs0005 40284, Sofia
Hs0005 40311, Sofia
Hs0005 40314, Sofia
Hs0005 40315, Sofia
Hs0005 40353, Stara Zagora
Hs0005 50233, Barrie
Hs0005 50172, Cobourg
Hs0005 50135, Edmonton
Hs0005 50174, London
Hs0005 50190, Richmond Hill
Hs0005 50192, Saskatoon
Hs0005 50133, Surrey
Hs0005 50134, Waterloo
Hs0005 50136, Winnipeg
Hs0005 40063, Prague
Hs0005 40194, Prague
Hs0005 40197, Amiens
Hs0005 40245, Antony
Hs0005 40321, Auxerre
Hs0005 40320, La Rochelle
Hs0005 40355, Le Mans
Hs0005 40247, Lyon
Hs0005 40130, Marseille
Hs0005 40132, Nice
Hs0005 40404, Reims
Hs0005 40318, Rouen
Hs0005 40403, Saint-Etienne
Hs0005 40246, Saint-Mandé
Hs0005 40285, Toulon
Hs0005 40286, Toulouse
Hs0005 40325, Berlin
Hs0005 40326, Berlin
Hs0005 40248, Bochum
Hs0005 40327, Bonn
Hs0005 40288, Darmstadt
Hs0005 40324, Dresden
Hs0005 40356, Dresden
Hs0005 40287, Frankfurt am Main
Hs0005 40142, Hamburg
Hs0005 40328, Hanover
Hs0005 40249, Kiel
Hs0005 40250, Lübeck
Hs0005 40174, Mainz
Hs0005 40323, München
Hs0005 40177, Münster
Hs0005 40251, Athens
Hs0005 40252, Efkarpia
Hs0005 40254, Debrecen
Hs0005 40344, Dublin
Hs0005 40261, Catania
Hs0005 40263, Roma
Hs0005 40258, Rozzano
Hs0005 40330, Torino
Hs0005 20196, Bunkyō City
Hs0005 20144, Fukuoka
Hs0005 20152, Ginowan
Hs0005 20043, Itabashi-ku
Hs0005 20195, Kagoshima
Hs0005 20170, Kurume
Hs0005 20190, Kyoto
Hs0005 20033, Nagoya
Hs0005 20178, Nishinomiya
Hs0005 20153, Obihiro
Hs0005 20037, Osaka
Hs0005 20154, Sapporo
Hs0005 20171, Sendai
Hs0005 40351, Breda
Hs0005 40292, Groningen
Hs0005 40264, Rotterdam
Hs0005 40347, Lodz
Hs0005 40293, Rzeszów
Hs0005 40335, Warsaw
Hs0005 40095, Wroclaw
Hs0005 40333, Wroclaw
Hs0005 40334, Wroclaw
Hs0005 40266, Badalona
Hs0005 40159, Barcelona
Hs0005 40267, Barcelona
Hs0005 40298, Granada
Hs0005 40294, Las Palmas de Gran Canaria
Hs0005 40268, Madrid
Hs0005 40297, Manises
Hs0005 40295, Pontevedra
Hs0005 40049, Seville
Hs0005 40230, Valencia
Hs0005 40406, Geneva
Hs0005 40270, Antalya
Hs0005 40273, Gaziantep
Hs0005 40272, Istanbul
Hs0005 40271, Izmir
Hs0005 40339, Leeds
UCB Biopharma SRL
INDUSTRY